{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:50:52Z","timestamp":1781229052929,"version":"3.54.1"},"reference-count":257,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Cognitive impairment is a prevalent non-motor symptom of Parkinson\u2019s disease (PD), increasing the risk of dementia as the disease progresses. Despite its clinical significance, the etiology of cognitive impairment in PD remains unclear. <jats:italic>Apolipoprotein E4 (APOE4)<\/jats:italic>, a well-known genetic risk factor of Alzheimer\u2019s disease, has been studied for its potential role in PD-related cognitive impairment. However, findings have been conflicting and thus inconclusive, highlighting a need to critically evaluate the current research. Several studies using neuroimaging modalities have explored the brains of individuals with PD and atypical parkinsonian disorders who have <jats:italic>APOE4<\/jats:italic>. Some of these studies have identified distinct neuropathological changes that have been previously reported to be associated with cognitive impairments in those with Parkinsonisms. Here, we review the role of <jats:italic>APOE4<\/jats:italic> on cognitive impairment in PD and atypical Parkinsonisms using neuroimaging evidence. We will examine how <jats:italic>APOE4<\/jats:italic> may contribute to pathological changes within the brain and its association with cognitive impairment.<\/jats:p>","DOI":"10.3389\/fnins.2025.1515374","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T06:38:47Z","timestamp":1740033527000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of Apolipoprotein E4 on cognitive impairment in Parkinson\u2019s disease and Parkinsonisms"],"prefix":"10.3389","volume":"19","author":[{"given":"Angenelle Eve","family":"Rosal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio P.","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e12117","DOI":"10.1002\/trc2.12117","article-title":"APOE \u03b54\/\u03b54 homozygotes with early Alzheimer\u2019s disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline","volume":"6","author":"Abushakra","year":"2020","journal-title":"A&D Transl. Res. Clin. Interv."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3906\/sag-2008-253","article-title":"Dopamine transporter SPECT imaging in Parkinson\u2019s disease and parkinsonian disorders","volume":"51","author":"Akdemir","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0177924","DOI":"10.1371\/journal.pone.0177924","article-title":"Regional brain amyloid-\u03b2 accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia","volume":"12","author":"Akhtar","year":"2017","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.trci.2019.02.001","article-title":"White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities","volume":"5","author":"Alber","year":"2019","journal-title":"Alzheimers Dement. (N Y)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","article-title":"Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice","volume":"30","author":"Andrews-Zwilling","year":"2010","journal-title":"J. Neurosci."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.neurobiolaging.2011.06.014","article-title":"Hippocampal and ventricular changes in Parkinson\u2019s disease mild cognitive impairment","volume":"33","author":"Apostolova","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","article-title":"Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study","volume":"141","author":"Attems","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.irn.2018.09.010","article-title":"Functional MRI in Parkinson\u2019s disease cognitive impairment","volume":"144","author":"Baggio","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/gps.381","article-title":"The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer\u2019s disease","volume":"16","author":"Ballard","year":"2001","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1212\/WNL.54.6.1304","article-title":"MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia","volume":"54","author":"Barber","year":"2000","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/archneur.56.8.961","article-title":"Apolipoprotein E \u24404 allele, temporal lobe atrophy, and white matter lesions in late-life dementias","volume":"56","author":"Barber","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e20221137","DOI":"10.1084\/jem.20221137","article-title":"A \u201cmulti-omics\u201d analysis of blood\u2013brain barrier and synaptic dysfunction in APOE4 mice","volume":"219","author":"Barisano","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/mds.25282","article-title":"CSF A\u03b2 levels correlate with structural brain changes in Parkinson\u2019s disease","volume":"28","author":"Beyer","year":"2013","journal-title":"Mov. Disord."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-016-0198-6","article-title":"Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"8","author":"Blanc","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e209418","DOI":"10.1212\/WNL.0000000000209418","article-title":"Association of plasma amyloid, P-tau, GFAP, and NfL with CSF, clinical, and cognitive features in patients with dementia with Lewy bodies","volume":"102","author":"Bolsewig","year":"2024","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1212\/WNL.0b013e3182a2cbd1","article-title":"Risk factors for dementia with Lewy bodies: a case-control study","volume":"81","author":"Boot","year":"2013","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s11357-023-00883-6","article-title":"Involvement of ApoE4 in dementia with Lewy bodies in the prodromal and demented stages: evaluation of the Strasbourg cohort","volume":"46","author":"Bousiges","year":"2023","journal-title":"GeroScience"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J. Neurosci."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jalz.2018.03.005","article-title":"Estimation of lifetime risks of Alzheimer\u2019s disease dementia using biomarkers for preclinical disease","volume":"14","author":"Brookmeyer","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1212\/WNL.0b013e3181c7da8e","article-title":"In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia","volume":"74","author":"Burack","year":"2010","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jalz.2018.01.016","article-title":"Effects of APOE-\u03b54 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer\u2019s disease","volume":"14","author":"Cacciaglia","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1212\/WNL.0b013e31829e6f94","article-title":"Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases","volume":"81","author":"Campbell","year":"2013","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e46289","DOI":"10.1371\/journal.pone.0046289","article-title":"Resting-state network disruption and APOE genotype in Alzheimer\u2019s disease: a lagged functional connectivity study","volume":"7","author":"Canuet","year":"2012","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.neuron.2023.03.021","article-title":"Cognitive heterogeneity in Parkinson\u2019s disease: a mechanistic view","volume":"111","author":"Carceles-Cordon","year":"2023","journal-title":"Neuron"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-019-0575-z","article-title":"Changes in gray matter volume and functional connectivity in dementia with Lewy bodies compared to Alzheimer\u2019s disease and normal aging: implications for fluctuations","volume":"12","author":"Chabran","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1142558","DOI":"10.3389\/fnagi.2023.1142558","article-title":"Predictors of cognitive impairment in newly diagnosed Parkinson\u2019s disease with normal cognition at baseline: a 5-year cohort study","volume":"15","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000339727","article-title":"Comparing hippocampal atrophy in Alzheimer\u2019s dementia and dementia with Lewy bodies","volume":"34","author":"Chow","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"136243","DOI":"10.1016\/j.neulet.2021.136243","article-title":"The impact of common genetic variants in cognitive decline in the first seven years of Parkinson\u2019s disease: a longitudinal observational study","volume":"764","author":"Chung","year":"2021","journal-title":"Neurosci. Lett."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/hbm.24631","article-title":"Frontal atrophy as a marker for dementia conversion in Parkinson\u2019s disease with mild cognitive impairment","volume":"40","author":"Chung","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fpsyt.2016.00089","article-title":"The genetic basis of cognitive impairment and dementia in Parkinson\u2019s disease","volume":"7","author":"Collins","year":"2016","journal-title":"Front. Psych."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer\u2019s disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1212\/01.wnl.0000304038.37421.cc","article-title":"APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease","volume":"70","author":"Cosentino","year":"2008","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1017\/neu.2019.28","article-title":"Systematic review of genetic variants associated with cognitive impairment and depressive symptoms in Parkinson\u2019s disease","volume":"32","author":"D\u2019Souza","year":"2020","journal-title":"Acta Neuropsychiatr."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.nicl.2018.09.025","article-title":"White matter hyperintensities are linked to future cognitive decline in de novo Parkinson\u2019s disease patients","volume":"20","author":"Dadar","year":"2018","journal-title":"Neuroimage Clin."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mds.23443","article-title":"Ventricular enlargement and mild cognitive impairment in early Parkinson\u2019s disease","volume":"26","author":"Dalaker","year":"2011","journal-title":"Mov. Disord."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"eaay3069","DOI":"10.1126\/scitranslmed.aay3069","article-title":"APOE genotype regulates pathology and disease progression in synucleinopathy","volume":"12","author":"Davis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13024-024-00767-z","article-title":"CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals","volume":"19","author":"del Campo","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"668559","DOI":"10.3389\/fnagi.2021.668559","article-title":"Posterior cortical cognitive deficits are associated with structural brain alterations in mild cognitive impairment in Parkinson\u2019s disease","volume":"13","author":"Devignes","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1212\/WNL.0000000000207393","article-title":"\u03b2-Amyloid load on PET along the continuum of dementia with Lewy bodies","volume":"101","author":"Diaz-Galvan","year":"2023","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","article-title":"APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology","volume":"91","author":"Dickson","year":"2018","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/alzrt274","article-title":"The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis","volume":"6","author":"Donaghy","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"S535","DOI":"10.3233\/JAD-2010-100342","article-title":"Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer\u2019s transgenic mice","volume":"20","author":"Dragicevic","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1212\/01.WNL.0000148478.39691.D3","article-title":"Cerebral glucose metabolism in patients with AD and different APOE genotypes","volume":"64","author":"Drzezga","year":"2005","journal-title":"Neurology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.trsl.2022.12.003","article-title":"Vascular contributions to Alzheimer\u2019s disease","volume":"254","author":"Eisenmenger","year":"2023","journal-title":"Transl. Res."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","article-title":"APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer\u2019s disease: a systematic review","volume":"12","author":"Emrani","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2008.10.018","article-title":"Lack of association of APOE and tau polymorphisms with dementia in Parkinson\u2019s disease","volume":"448","author":"Ezquerra","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2076942","article-title":"Cognition deficits in Parkinson\u2019s disease: mechanisms and treatment","volume":"2020","author":"Fang","year":"2020","journal-title":"Parkinsons Dis."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","article-title":"Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults","volume":"91","author":"Farrell","year":"2018","journal-title":"Neurology"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.nbd.2012.02.002","article-title":"A large study reveals no association between APOE and Parkinson\u2019s disease","volume":"46","author":"Federoff","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11357-021-00450-x","article-title":"Apolipoprotein E \u025b4\u2013related effects on cognition are limited to the Alzheimer\u2019s disease spectrum","volume":"44","author":"Fern\u00e1ndez","year":"2021","journal-title":"GeroScience"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the Bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases","volume":"17","author":"Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neurobiolaging.2021.04.029","article-title":"Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies","volume":"105","author":"Ferreira","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e3257","DOI":"10.1212\/WNL.0000000000010943","article-title":"\u03b2-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies","volume":"95","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e846","DOI":"10.1212\/WNL.0000000000201579","article-title":"Cross-sectional associations of \u03b2-amyloid, tau, and cerebrovascular biomarkers with neurodegeneration in probable dementia with Lewy bodies","volume":"100","author":"Ferreira","year":"2023","journal-title":"Neurology"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","article-title":"Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice","volume":"32","author":"Fitz","year":"2012","journal-title":"J. Neurosci."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"10365","DOI":"10.1523\/JNEUROSCI.0630-07.2007","article-title":"In vitro characterization of Pittsburgh compound-B binding to Lewy bodies","volume":"27","author":"Fodero-Tavoletti","year":"2007","journal-title":"J. Neurosci."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11910-018-0835-5","article-title":"Lewy body disease: clinical and pathological \u201coverlap syndrome\u201d between synucleinopathies (Parkinson disease) and tauopathies (Alzheimer disease)","volume":"18","author":"Foguem","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/WNL.0b013e31821ccc83","article-title":"Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease","volume":"76","author":"Galvin","year":"2011","journal-title":"Neurology"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00259-012-2198-5","article-title":"Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson\u2019s disease","volume":"39","author":"Garcia-Garcia","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11682-017-9751-6","article-title":"Parkinson\u2019s disease with mild cognitive impairment: severe cortical thinning antedates dementia","volume":"13","author":"Gasca-Salas","year":"2019","journal-title":"Brain Imaging Behav."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13195-020-00740-0","article-title":"The association of APOE \u03b54 with cognitive function over the adult life course and incidence of dementia: 20\u202fyears follow-up of the Whitehall II study","volume":"13","author":"Gharbi-Meliani","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"937133","DOI":"10.3389\/fnmol.2022.937133","article-title":"Neuronal cell death mechanisms in Alzheimer\u2019s disease: an insight","volume":"15","author":"Goel","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jnen\/nlx026","article-title":"The lateral temporal lobe in early human life","volume":"76","author":"Goldstein","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/mds.25048","article-title":"Brain amyloid and cognition in Lewy body diseases","volume":"27","author":"Gomperts","year":"2012","journal-title":"Mov. Disord."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/brain\/awv104","article-title":"Parkinson\u2019s disease dementia: a neural networks perspective","volume":"138","author":"Gratwicke","year":"2015","journal-title":"Brain"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"20S","DOI":"10.2967\/jnumed.121.263196","article-title":"Tau PET imaging in neurodegenerative disorders","volume":"63","author":"Groot","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1369733","DOI":"10.3389\/fnagi.2024.1369733","article-title":"Cognitive dysfunction in animal models of human lewy-body dementia","volume":"16","author":"Haikal","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3174\/ajnr.A5184","article-title":"APOE*E4 is associated with Gray matter loss in the posterior cingulate cortex in healthy elderly controls subsequently developing subtle cognitive decline","volume":"38","author":"Haller","year":"2017","journal-title":"Am. J. Neuroradiol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/3217960","article-title":"Structural neuroimaging markers of cognitive decline in Parkinson\u2019s disease","volume":"2016","author":"Hanganu","year":"2016","journal-title":"Parkinsons Dis."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnen\/nlw070","article-title":"Distribution and load of amyloid-\u03b2 pathology in Parkinson disease and dementia with Lewy bodies","volume":"75","author":"Hepp","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"788846","DOI":"10.3389\/fnagi.2022.788846","article-title":"Magnetic resonance imaging markers for cognitive impairment in Parkinson\u2019s disease: current view","volume":"14","author":"Hou","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e0175560","DOI":"10.1371\/journal.pone.0175560","article-title":"Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson\u2019s disease","volume":"12","author":"Huertas","year":"2017","journal-title":"PLoS One"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"NS20180203","DOI":"10.1042\/NS20180203","article-title":"The role of APOE4 in Alzheimer\u2019s disease: strategies for future therapeutic interventions","volume":"3","author":"Hunsberger","year":"2019","journal-title":"Neuronal Signal."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"630502","DOI":"10.3389\/fnins.2021.630502","article-title":"APOE and Alzheimer\u2019s disease: from lipid transport to physiopathology and therapeutics","volume":"15","author":"Husain","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","article-title":"Age-specific population frequencies of cerebral \u03b2-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study","volume":"13","author":"Jack","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer\u2019s disease","volume":"15","author":"Jahn","year":"2013","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"ref95","article-title":"Physiology, cerebral cortex functions","volume-title":"StatPearls","author":"Jawabri","year":"2023"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease?","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Med."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","article-title":"APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology","volume":"143","author":"Jin","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2017.12.018","article-title":"White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease","volume":"385","author":"Joki","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neurobiolaging.2021.06.004","article-title":"Apolipoprotein E4, amyloid, and cognition in Alzheimer\u2019s and Lewy body disease","volume":"106","author":"Jung","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/brain\/awab402","article-title":"Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups","volume":"145","author":"Kaivola","year":"2021","journal-title":"Brain"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/NEN.0b013e31816362aa","article-title":"Striatal \u03b2-amyloid deposition in Parkinson disease with dementia","volume":"67","author":"Kalaitzakis","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.dadm.2016.03.001","article-title":"White matter hyperintensities are more highly associated with preclinical Alzheimer\u2019s disease than imaging and cognitive markers of neurodegeneration","volume":"4","author":"Kandel","year":"2016","journal-title":"Alzheimers Dement. (Amst)"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1212\/WNL.0000000000008818","article-title":"\u03b2-Amyloid PET and neuropathology in dementia with Lewy bodies","volume":"94","author":"Kantarci","year":"2020","journal-title":"Neurology"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-150348","article-title":"Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer\u2019s disease prevention and early intervention","volume":"48","author":"Keeney","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e2429","DOI":"10.1212\/WNL.0000000000011852","article-title":"Association of physical activity and APOE genotype with longitudinal cognitive change in early Parkinson disease","volume":"96","author":"Kim","year":"","journal-title":"Neurology"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2021.01.004","article-title":"Impact of the apolipoprotein E \u03b54 allele on early Parkinson\u2019s disease progression","volume":"83","author":"Kim","year":"","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00429-014-0785-x","article-title":"Imaging changes associated with cognitive abnormalities in Parkinson\u2019s disease","volume":"220","author":"Koshimori","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cns.13216","article-title":"Exploring the bi-directional relationship between autophagy and Alzheimer\u2019s disease","volume":"26","author":"Kuang","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"9540","DOI":"10.3390\/ijms23179540","article-title":"Dysfunctional glucose metabolism in Alzheimer\u2019s disease onset and potential pharmacological interventions","volume":"23","author":"Kumar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/0891988709332945","article-title":"APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study","volume":"22","author":"Kurz","year":"2009","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","article-title":"Cortical \u03b1-synuclein load is associated with amyloid-\u03b2 plaque burden in a subset of Parkinson\u2019s disease patients","volume":"115","author":"Lashley","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/alz.12610","article-title":"Role of chronic neuroinflammation in neuroplasticity and cognitive function: a hypothesis","volume":"18","author":"Lecca","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"e0269787","DOI":"10.1371\/journal.pone.0269787","article-title":"The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments","volume":"17","author":"Li","year":"2022","journal-title":"PLoS One"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s00415-018-9100-8","article-title":"Amyloid-\u03b2 and Parkinson\u2019s disease","volume":"266","author":"Lim","year":"2019","journal-title":"J. Neurol."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/brain\/awt286","article-title":"Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer\u2019s disease","volume":"137","author":"Lim","year":"2014","journal-title":"Brain"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/brain\/awl054","article-title":"Reduced functional brain activity response in cognitively intact apolipoprotein E \u03b54 carriers","volume":"129","author":"Lind","year":"2006","journal-title":"Brain"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/mdc3.12956","article-title":"White matter hyperintensities related to Parkinson\u2019s disease executive function","volume":"7","author":"Linortner","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/acn3.51429","article-title":"The influence of white matter hyperintensity on cognitive impairment in Parkinson\u2019s disease","volume":"8","author":"Liu","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3233\/JAD-220976","article-title":"Age-related association between APOE \u025b4 and cognitive progression in de novo Parkinson\u2019s disease","volume":"91","author":"Liu","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3233\/JAD-2010-100201","article-title":"Effect of APOE \u03b54 allele on cortical thicknesses and volumes: the AddNeuroMed study","volume":"21","author":"Liu","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.dadm.2018.11.003","article-title":"Serum levels of proteins involved in amyloid-\u03b2 clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment","volume":"11","author":"Liu","year":"2019","journal-title":"Alzheimers Dement. (Amst)"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 accelerates early seeding of amyloid pathology","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/brain\/awm191","article-title":"PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis","volume":"130","author":"Lockhart","year":"2007","journal-title":"Brain"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","article-title":"Alterations in cholesterol metabolism as a risk factor for developing Alzheimer\u2019s disease: potential novel targets for treatment","volume":"190","author":"Loera-Valencia","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2008.12.008","article-title":"Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics","volume":"34","author":"Maetzler","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuroimage.2007.09.072","article-title":"[11C]PIB binding in Parkinson\u2019s disease dementia","volume":"39","author":"Maetzler","year":"2008","journal-title":"NeuroImage"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"102684","DOI":"10.1016\/j.conb.2023.102684","article-title":"Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer\u2019s disease","volume":"79","author":"Mahley","year":"2023","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-018-0249-5","article-title":"Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury","volume":"13","author":"Main","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","article-title":"Risk factors for non-motor symptoms in Parkinson\u2019s disease","volume":"17","author":"Marinus","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-017-0482-0","article-title":"Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson\u2019s case","volume":"5","author":"Marqui\u00e9","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE Cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000464322","article-title":"Extremely low prevalence of amyloid positron emission tomography positivity in Parkinson\u2019s disease without dementia","volume":"77","author":"Mashima","year":"2017","journal-title":"Eur. Neurol."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"100155","DOI":"10.1016\/j.prdoa.2022.100155","article-title":"Imaging pathological tau in atypical Parkinsonisms: a review","volume":"7","author":"Mena","year":"2022","journal-title":"Clin. Park. Relat. Disord."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13195-019-0535-7","article-title":"Association between increased levels of amyloid-\u03b2 oligomers in plasma and episodic memory loss in Alzheimer\u2019s disease","volume":"11","author":"Meng","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parkreldis.2016.04.013","article-title":"Apolipoprotein E \u03b54 does not affect cognitive performance in patients with Parkinson\u2019s disease","volume":"29","author":"Mengel","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","article-title":"18F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairment","volume":"58","author":"Meyer","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13041-022-00964-1","article-title":"Beta amyloid deposition and cognitive decline in Parkinson\u2019s disease: a study of the PPMI cohort","volume":"15","author":"Mihaescu","year":"2022","journal-title":"Mol. Brain"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"e1807","DOI":"10.1212\/WNL.0000000000008377","article-title":"APOE \u03b54, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia","volume":"93","author":"Mirza","year":"2019","journal-title":"Neurology"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s00415-018-8800-4","article-title":"Mild cognitive impairment in Parkinson\u2019s disease: the Parkinson\u2019s disease cognitive study (PACOS)","volume":"265","author":"Monastero","year":"2018","journal-title":"J. Neurol."},{"key":"ref146","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.parkreldis.2014.02.001","article-title":"Clinical and pathologic presentation in Parkinson\u2019s disease by apolipoprotein e4 allele status","volume":"20","author":"Monsell","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/STROKEAHA.119.028814","article-title":"APOE4 accelerates development of dementia after stroke: is there a role for cerebrovascular dysfunction?","volume":"51","author":"Montagne","year":"2020","journal-title":"Stroke"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mds.24946","article-title":"Genetic influences on cognitive decline in Parkinson\u2019s disease","volume":"27","author":"Morley","year":"2012","journal-title":"Mov. Disord."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/gps.4039","article-title":"Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review","volume":"29","author":"Morra","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1212\/WNL.0000000000200344","article-title":"Proteinopathy and longitudinal cognitive decline in Parkinson disease","volume":"99","author":"Myers","year":"2022","journal-title":"Neurology"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/WAD.0000000000000479","article-title":"Role of Apolipoprotein E in the clinical profile of atypical parkinsonian syndromes","volume":"36","author":"Nasri","year":"2022","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/biom13101435","article-title":"Autophagy in Parkinson\u2019s disease","volume":"13","author":"Nechushtai","year":"2023","journal-title":"Biomol. Ther."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"e1916439","DOI":"10.1001\/jamanetworkopen.2019.16439","article-title":"Association of longitudinal \u03b2-amyloid accumulation determined by positron emission tomography with clinical and cognitive decline in adults with probable Lewy body dementia","volume":"2","author":"Nedelska","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181bacf9e","article-title":"Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies","volume":"73","author":"Nelson","year":"2009","journal-title":"Neurology"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neurobiolaging.2020.06.010","article-title":"Gray matter changes related to microglial activation in Alzheimer\u2019s disease","volume":"94","author":"Nicastro","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pscychresns.2016.07.006","article-title":"Voxel-based morphometry to detect effect of APOE on brain gray matter changes in Parkinson\u2019s disease","volume":"254","author":"Nicoletti","year":"2016","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jns.2014.09.049","article-title":"Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson\u2019s disease with mild cognitive impairment","volume":"347","author":"Noh","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"137","author":"Nombela","year":"2014","journal-title":"Brain"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/bs.irn.2017.05.002","article-title":"Cognition in Parkinson\u2019s disease","volume":"133","author":"O\u2019Callaghan","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41531-022-00411-x","article-title":"APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson\u2019s disease","volume":"8","author":"Okubadejo","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1176\/appi.ajp.161.9.1603","article-title":"Middle and inferior temporal gyrus Gray matter volume abnormalities in chronic schizophrenia: an MRI study","volume":"161","author":"Onitsuka","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1212\/WNL.0b013e31827f0889","article-title":"Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia","volume":"80","author":"Ossenkoppele","year":"2013","journal-title":"Neurology"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","article-title":"Dementia with Lewy bodies: an update and outlook","volume":"14","author":"Outeiro","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref164","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.nbd.2012.03.029","article-title":"Cognitive impairment and dementia in Parkinson\u2019s disease","volume":"46","author":"Pagonabarraga","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41422-021-00582-x","article-title":"An app knock-in rat model for Alzheimer\u2019s disease exhibiting A\u03b2 and tau pathologies, neuronal death and cognitive impairments","volume":"32","author":"Pang","year":"2022","journal-title":"Cell Res."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.20663","article-title":"Presence of an APOE4 allele results in significantly earlier onset of Parkinson\u2019s disease and a higher risk with dementia","volume":"21","author":"Pankratz","year":"2006","journal-title":"Mov. Disord."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.smim.2022.101594","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin. Immunol."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1006\/geno.2002.6707","article-title":"Parkinson\u2019s disease and Apolipoprotein E: possible association with dementia but not age at onset","volume":"79","author":"Parsian","year":"2002","journal-title":"Genomics"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"15226","DOI":"10.1073\/pnas.1821409116","article-title":"\u03b1-Synuclein\u2212lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson\u2019s disease patients","volume":"116","author":"Paslawski","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-150762","article-title":"APOE, MAPT, and COMT and Parkinson\u2019s disease susceptibility and cognitive symptom progression","volume":"6","author":"Paul","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/1533317514525655","article-title":"Cognitive, neuropsychiatric, and motor features associated with Apolipoprotein E \u220a4 allele in a sample of Bulgarian patients with late-onset Parkinson\u2019s disease","volume":"29","author":"Pavlova","year":"2014","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","article-title":"Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study","volume":"88","author":"Pedersen","year":"2017","journal-title":"Neurology"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.nicl.2014.03.013","article-title":"fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies","volume":"4","author":"Peraza","year":"2014","journal-title":"NeuroImage Clin."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archneurol.2011.666","article-title":"Subjective cognition and amyloid deposition imaging: a Pittsburgh compound B positron emission tomography study in normal elderly individuals","volume":"69","author":"Perrotin","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","article-title":"Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review","volume":"30","author":"Petrou","year":"2015","journal-title":"Mov. Disord."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"166793","DOI":"10.1016\/j.bbadis.2023.166793","article-title":"Apolipoprotein E \u03b54 triggers neurotoxicity via cholesterol accumulation, acetylcholine dyshomeostasis, and PKC\u03b5 mislocalization in cholinergic neuronal cells","volume":"1869","author":"Piccarducci","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.pjnns.2018.04.003","article-title":"The impact of Apolipoprotein E alleles on cognitive performance in patients with Parkinson\u2019s disease","volume":"52","author":"Pierzchli\u0144ska","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer\u2019s disease pathogenesis\u2014mitochondrial deregulation and targeted therapeutic strategies","volume":"24","author":"Pires","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"e1002254","DOI":"10.1371\/journal.pmed.1002254","article-title":"APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts","volume":"14","author":"Qian","year":"2017","journal-title":"PLoS Med."},{"key":"ref180","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40478-021-01154-1","article-title":"Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer\u2019s pathophysiology","volume":"9","author":"Ramanan","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.dadm.2018.08.004","article-title":"Amnestic mild cognitive impairment individuals with dissimilar pathologic origins show common regional vulnerability in the default mode network","volume":"10","author":"Rane","year":"2018","journal-title":"Alzheimers Dement. (Amst)"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.biochi.2005.10.007","article-title":"Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes","volume":"88","author":"Rapp","year":"2006","journal-title":"Biochimie"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-017-0064-8","article-title":"Apolipoprotein-E (Apoe) \u03b54 and cognitive decline over the adult life course","volume":"8","author":"Rawle","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/brain\/awac414","article-title":"Association between the LRP1B and APOE loci and the development of Parkinson\u2019s disease dementia","volume":"146","author":"Real","year":"2023","journal-title":"Brain"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JAD-2010-1255","article-title":"Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia","volume":"19","author":"Reitz","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref187","doi-asserted-by":"publisher","first-page":"002","DOI":"10.23937\/IJND-2017\/1710002","article-title":"Apolipoprotein E fragmentation within Lewy bodies of the human Parkinson\u2019s disease brain","volume":"1","author":"Rohn","year":"2018","journal-title":"Int. J. Neurodegener. Dis."},{"key":"ref188","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1038\/s41598-019-43458-2","article-title":"GBA and APOE \u03b54 associate with sporadic dementia with Lewy bodies in European genome wide association study","volume":"9","author":"Rongve","year":"2019","journal-title":"Sci. Rep."},{"key":"ref189","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jalz.2018.04.005","article-title":"APOE -\u03b54 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"14","author":"Saeed","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3389\/fnins.2017.00712","article-title":"Apolipoprotein E\u03b54: a biomarker for executive dysfunction among Parkinson\u2019s disease patients with mild cognitive impairment","volume":"11","author":"Samat","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref192","doi-asserted-by":"publisher","first-page":"112039","DOI":"10.1016\/j.bbr.2019.112039","article-title":"Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson\u2019s disease","volume":"372","author":"Sampedro","year":"2019","journal-title":"Behav. Brain Res."},{"key":"ref193","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.parkreldis.2015.08.024","article-title":"Mild cognitive impairment in newly diagnosed Parkinson\u2019s disease: a longitudinal prospective study","volume":"21","author":"Santangelo","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref194","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fneur.2020.00047","article-title":"Imaging mild cognitive impairment and dementia in Parkinson\u2019s disease","volume":"11","author":"Sasikumar","year":"2020","journal-title":"Front. Neurol."},{"key":"ref195","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/mds.25982","article-title":"Cortical thinning associated with mild cognitive impairment in Parkinson\u2019s disease","volume":"29","author":"Segura","year":"2014","journal-title":"Mov. Disord."},{"key":"ref196","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref197","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3389\/fnins.2020.00857","article-title":"Mapping the interactive effects of ApoE gene polymorphism on caudate functional connectivity in mild cognitive impairment associated with Parkinson\u2019s disease","volume":"14","author":"Shang","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref198","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0973-6131.146070","article-title":"A randomized controlled pilot study of the therapeutic effects of yoga in people with Parkinson\u2019s disease","volume":"8","author":"Sharma","year":"2015","journal-title":"Int. J. Yoga"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3233\/JAD-201295","article-title":"The effect of GBA mutations and APOE polymorphisms on dementia with Lewy bodies in Ashkenazi Jews","volume":"80","author":"Shiner","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref201","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.55.7.964","article-title":"Risk estimates of dementia by Apolipoprotein E genotypes from a population-based incidence study: the Rotterdam study","volume":"55","author":"Slooter","year":"1998","journal-title":"Arch. Neurol."},{"key":"ref202","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1148\/radiol.10100307","article-title":"Apolipoprotein E and Gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease","volume":"258","author":"Spampinato","year":"2011","journal-title":"Radiology"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.28932","article-title":"GBA and APOE impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study","volume":"37","author":"Szwedo","year":"2022","journal-title":"Mov. Disord."},{"key":"ref204","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mds.28342","article-title":"Genome-wide association studies of cognitive and motor progression in Parkinson\u2019s disease","volume":"36","author":"Tan","year":"2021","journal-title":"Mov. Disord."},{"key":"ref205","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0002-9440(10)64963-2","article-title":"Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice","volume":"156","author":"Tesseur","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref206","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1007\/s12035-017-0757-2","article-title":"Transcriptional effects of ApoE4: relevance to Alzheimer\u2019s disease","volume":"55","author":"Theendakara","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref207","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5603\/PJNNS.a2021.0071","article-title":"Effects of sex and APOE on Parkinson\u2019s disease-related cognitive decline","volume":"55","author":"Tipton","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref208","article-title":"Dopamine and Parkinson\u2019s disease","volume-title":"Madame curie bioscience database [internet]","author":"Triarhou","year":"2013"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-4-1","article-title":"Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer\u2019s disease: a cross-sectional study","volume":"4","author":"Trivedi","year":"2006","journal-title":"BMC Med."},{"key":"ref210","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/mds.27204","article-title":"APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson\u2019s disease","volume":"33","author":"Tropea","year":"2018","journal-title":"Mov. Disord."},{"key":"ref211","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03b54 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref212","doi-asserted-by":"publisher","first-page":"631145","DOI":"10.3389\/fneur.2021.631145","article-title":"APOE and MAPT are associated with dementia in neuropathologically confirmed Parkinson\u2019s disease","volume":"12","author":"Tunold","year":"2021","journal-title":"Front. Neurol."},{"key":"ref213","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-Synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref214","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/08919887211060019","article-title":"APOE4 allele, sex, and dementia risk in Parkinson\u2019s disease: lessons from a longitudinal cohort","volume":"35","author":"Umeh","year":"2022","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref215","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.02.006","article-title":"Cortical atrophy patterns in early Parkinson\u2019s disease patients using hierarchical cluster analysis","volume":"50","author":"Uribe","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/420957","article-title":"Dementia in Parkinson\u2019s disease correlates with \u03b1-synuclein pathology but not with cortical astrogliosis","volume":"2012","author":"van den Berge","year":"2012","journal-title":"Parkinsons Dis."},{"key":"ref217","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.euroneuro.2010.03.008","article-title":"Exploring the brain network: a review on resting-state fMRI functional connectivity","volume":"20","author":"van den Heuvel","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref218","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S1474-4422(18)30053-X","article-title":"The effect of APOE and other common genetic variants on the onset of Alzheimer\u2019s disease and dementia: a community-based cohort study","volume":"17","author":"van der Lee","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref219","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2018.07.005","article-title":"Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer\u2019s disease pathology","volume":"71","author":"van der Zande","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/archneurol.2009.97","article-title":"Dysfunction of the default mode network in Parkinson disease","volume":"66","author":"van Eimeren","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref221","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13195-019-0537-5","article-title":"Amyloid-\u03b2 peptides in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"11","author":"van Steenoven","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"ref222","first-page":"797","article-title":"Cerebral metabolic differences in Parkinson\u2019s and Alzheimer\u2019s diseases matched for dementia severity","volume":"38","author":"Vander Borght","year":"1997","journal-title":"J. Nucl. Med."},{"key":"ref223","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref224","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jalz.2013.03.010","article-title":"High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia","volume":"10","author":"Vijayaraghavan","year":"2014","journal-title":"Alzheimers Dement."},{"key":"ref225","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref226","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-019-0172-x","article-title":"Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities","volume":"8","author":"Visanji","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref227","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","article-title":"APOE genotype-specific differences in the innate immune response","volume":"30","author":"Vitek","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref228","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/B978-0-444-64196-0.00013-3","article-title":"Cingulate cortex in Parkinson\u2019s disease","volume":"166","author":"Vogt","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"ref229","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13195-024-01502-y","article-title":"Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies","volume":"16","author":"Vrillon","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"ref230","doi-asserted-by":"publisher","first-page":"777706","DOI":"10.3389\/fnsys.2021.777706","article-title":"It is time to study overlapping molecular and circuit Pathophysiologies in Alzheimer\u2019s and Lewy body disease spectra","volume":"15","author":"Wakasugi","year":"2021","journal-title":"Front. Syst. Neurosci."},{"key":"ref231","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3233\/JAD-142556","article-title":"Apolipoprotein E \u03b54 modulates cognitive profiles, hippocampal volume, and resting-state functional connectivity in Alzheimer\u2019s disease","volume":"45","author":"Wang","year":"2015","journal-title":"JAD"},{"key":"ref232","doi-asserted-by":"publisher","first-page":"e001140","DOI":"10.1161\/JAHA.114.001140","article-title":"What are white matter hyperintensities made of?","volume":"4","author":"Wardlaw","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref233","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1750-3639.2010.00373.x","article-title":"Profile of cognitive impairment in Parkinson\u2019s disease","volume":"20","author":"Watson","year":"2010","journal-title":"Brain Pathol."},{"key":"ref234","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/alzrt182","article-title":"Comprehensive behavioral characterization of an APP\/PS-1 double knock-in mouse model of Alzheimer\u2019s disease","volume":"5","author":"Webster","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"ref235","first-page":"195","article-title":"Evidence for impaired encoding and retrieval memory profiles in Parkinson disease","volume":"17","author":"Weintraub","year":"2004","journal-title":"Cogn. Behav. Neurol."},{"key":"ref236","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/alzrt250","article-title":"Performance on a pattern separation task by Alzheimer\u2019s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E \u22084 status and cerebrospinal fluid amyloid-\u03b242 levels","volume":"6","author":"Wesnes","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"ref237","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between A\u03b2 and memory in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J. Neurosci."},{"key":"ref238","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/alzrt187","article-title":"Evidence for impaired amyloid \u03b2 clearance in Alzheimer\u2019s disease","volume":"5","author":"Wildsmith","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"ref239","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","article-title":"Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson\u2019s disease","volume":"256","author":"Williams-Gray","year":"2009","journal-title":"J. Neurol."},{"key":"ref240","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3969\/j.issn.1673-5374.2013.14.004","article-title":"Changes of brain gray matter structure in Parkinson\u2019s disease patients with dementia","volume":"8","author":"Xia","year":"2013","journal-title":"Neural Regen. Res."},{"key":"ref241","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/brain\/awn254","article-title":"The influence of parental history of Alzheimer\u2019s disease and apolipoprotein E \u03b54 on the BOLD signal during recognition memory","volume":"132","author":"Xu","year":"2009","journal-title":"Brain"},{"key":"ref242","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s00415-016-8122-3","article-title":"Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson\u2019s disease","volume":"263","author":"Xu","year":"2016","journal-title":"J. Neurol."},{"key":"ref243","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref244","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s11682-022-00698-7","article-title":"Semantic fluency deficits and associated brain activity in Parkinson\u2019s disease with mild cognitive impairment","volume":"16","author":"Yang","year":"2022","journal-title":"Brain Imaging Behav."},{"key":"ref245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-023-00592-z","article-title":"White matter changes in Parkinson\u2019s disease","volume":"9","author":"Yang","year":"2023","journal-title":"npj Parkinsons Dis."},{"key":"ref246","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000479057","article-title":"Dementia-predicting cognitive risk score and its correlation with cortical thickness in Parkinson disease","volume":"44","author":"Ye","year":"2017","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref247","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/life13071472","article-title":"Exploring the Frontiers of neuroimaging: a review of recent advances in understanding brain functioning and disorders","volume":"13","author":"Yen","year":"2023","journal-title":"Life (Basel)"},{"key":"ref248","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"key":"ref249","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neurobiolaging.2023.07.011","article-title":"Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson\u2019s disease","volume":"131","author":"Zenuni","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"ref250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Sig. Transduct. Target Ther."},{"key":"ref251","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1523\/JNEUROSCI.0455-20.2020","article-title":"The chemokine-like receptor 1 deficiency improves cognitive deficits of AD mice and attenuates tau hyperphosphorylation via regulating tau seeding","volume":"40","author":"Zhang","year":"2020","journal-title":"J. Neurosci."},{"key":"ref252","first-page":"15383","article-title":"Gray matter atrophy in patients with Parkinson\u2019s disease and those with mild cognitive impairment: a voxel-based morphometry study","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref253","doi-asserted-by":"publisher","first-page":"eaay1809","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref254","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"ref255","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-021-02361-9","article-title":"Apolipoprotein E regulates lipid metabolism and \u03b1-synuclein pathology in human iPSC-derived cerebral organoids","volume":"142","author":"Zhao","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref256","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s40001-024-01924-2","article-title":"Association analyses of apolipoprotein E genotypes and cognitive performance in patients with Parkinson\u2019s disease","volume":"29","author":"Zhu","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref257","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cns.12677","article-title":"The role of neuroinflammation and amyloid in cognitive impairment in an APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease","volume":"23","author":"Zhu","year":"2017","journal-title":"CNS Neurosci. Ther."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1515374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T06:38:55Z","timestamp":1740033535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1515374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":257,"alternative-id":["10.3389\/fnins.2025.1515374"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1515374","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"article-number":"1515374"}}